The declaration window for the Pharmacy Quality Scheme (PQS) 2022/23 is now open. Community pharmacy contractors can make a claim for a PQS payment up until 11.59pm on Friday 3rd March 2023 through the MYS portal. Contractors must have evidence to demonstrate meeting the gateway criteria and the domains that they have claimed for by the end [...]
The post PQS: Declaration window is open appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Zopiclone 3.75mg tablets. MSN/2023/006 Tier 2 – medium impact Date of issue 3rd February 2023 Zopiclone 3.75mg tablets are out of stock from 30th January until mid-February 2023. Certain brands of zopiclone 7.5mg tablets, which include a break line and can [...]
The post Medicine Supply Notification: Zopiclone 3.75mg tablets appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Fluoxetine 20mg/5mL oral solution and fluoxetine (Olena®) 20mg dispersible tablets. MSN/2023/007 Tier 2 – medium impact Date of issue 3rd February 2023 Fluoxetine 20mg/5mL oral solution is in limited supply until March 2023. Fluoxetine (Olena®) 20mg dispersible tablets are out of [...]
The post Medicine Supply Notification: Fluoxetine 20mg/5mL oral solution and fluoxetine (Olena® ) 20mg dispersible tablets appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Estradot ®) 25micrograms/24hours, 50micrograms/24hours and 100micrograms/24hours patches. MSN/2023/009 Tier 2 – medium impact Date of issue 3rd February 2023 Estradiol (Estradot®) 25microgram/24hours patches are out of stock until w/c 13th February 2023. Estradiol (Estradot®) 50microgram/24hours patches are out of stock [...]
The post Medicine Supply Notification: Estradiol (Estradot ® ) 25micrograms/24hours, 50micrograms/24hours and 100micrograms/24hours patches appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfasalazine (Salazopyrin®) 500mg suppositories. MSN/2023/008 Tier 2 – medium impact Date of issue 3rd February 2023 Sulfasalazine (Salazopyrin®) 500mg suppositories will be out of stock from 6th February until w/c 20th March 2023. Alternative aminosalicylic acid (5-ASA) containing suppositories are available [...]
The post Medicine Supply Notification: Sulfasalazine (Salazopyrin®) 500mg suppositories appeared first on PSNC Website.
Recent Comments